Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes.

Tim Heise J Hans DeVries Shweta UrvaJing LiEdward John Pratt Melissa K ThomasKieren J MatherChrisanthi A KaranikasJulia P Dunn Axel Haupt Zvonko Milicevic Tamer Coskun

Published in: Diabetes care (2023)

Differences in energy intake during ad libitum lunch were not sufficient to explain the different weight outcomes. Further evaluation is needed to assess mechanistic differences related to tirzepatide actions on 24-h energy intake, substrate utilization, and energy expenditure.

Keyphrases

weight gain
weight loss
adipose tissue
body mass index
body weight
physical activity
type diabetes
fatty acid